Injeq Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 16


  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.28M

  • Investors
  • 4

Injeq General Information


Manufacturer of a bio-impedance measurement device designed to help in promoting efficiency in surgeries. The company's device specializes in the form of a needle that knows the physiological condition of organs and also performs tissue identification, enabling surgeons to perform high-precision surgeries with perfection and efficiency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Corporate Office
  • Biokatu 8
  • 33520 Tampere
  • Finland
+358 040 0000000

Injeq Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Injeq Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 21-Apr-2022 $3.28M 00.000 Completed Generating Revenue
7. Later Stage VC 01-Jan-2021 00.000 Completed Generating Revenue
6. Equity Crowdfunding 18-Nov-2020 00.000 00.000 0000 Completed Generating Revenue
5. Equity Crowdfunding 31-Jul-2019 00.000 00.000 000.00 Completed Generating Revenue
4. Debt - General 01-Jan-2017 00000 00.000 Completed Generating Revenue
3. Grant 01-Jan-2017 00000 00000 Completed Generating Revenue
2. Later Stage VC 21-Dec-2016 $272K Completed Generating Revenue
1. Seed Round 29-Dec-2015 $272K $272K 00.000 Completed Startup
To view Injeq’s complete valuation and funding history, request access »

Injeq Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.00 00.00 00 00.00 00.000
Ordinary 0,000,000 00.00 00.00 00 00.00 00.000
Ordinary 129,792 $2.28 $2.28 1x $2.28 2.87%
To view Injeq’s complete cap table history, request access »

Injeq Comparisons

HQ Location
Total Raised
Post Valuation
Manufacturer of a bio-impedance measurement device designed to help in promoting efficiency in surgeries. The company's
Medical Supplies
Tampere, Finland
16 As of 2023
0000000000 0 00.000


sum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididun
0000000 00000000
Wijnegem, Belgium
00 As of 0000
000000&0 00.000


ation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure d
0000000 00000000
Ness Ziona, Israel
00 As of 0000
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Injeq Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novosanis Formerly VC-backed Wijnegem, Belgium 00 00.000 000000&0 00.000
NanoPass Technologies Venture Capital-Backed Ness Ziona, Israel 00 0000 00000000000 0000
PharmaJet Venture Capital-Backed Golden, CO 00 0000 0000000000 0 0000
You’re viewing 3 of 3 competitors. Get the full list »

Injeq Executive Team (13)

Name Title Board Seat Contact Info
Timo Hänninen Chief Executive Officer
Satu Sinisalo Chief Financial Officer
Timo Elomaa Chief Operating Officer
Harri Sievänen Chief Scientific Officer
Petri Ahonen Chief Manufacturing Officer
You’re viewing 5 of 13 executive team members. Get the full list »

Injeq Board Members (11)

Name Representing Role Since
Jari Hyttinen Ph.D Injeq Co-Founder & Board Member 000 0000
Pekka Tammela Self Board Member 000 0000
Piritta Setala Self Board Member 000 0000
Tomi Numminen Self Chairman 000 0000
Tommi Majaus Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Injeq Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Injeq Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Tesi Fund of Funds Minority 000 0000 000000 0
Ely Keskus Government Minority 000 0000 000000 0
Finnish Business Angels Network Not-For-Profit Venture Capital Minority 000 0000 000000 0
Finnvera Lender/Debt Provider Minority 000 0000 000000 0
To view Injeq’s complete investors history, request access »

Injeq FAQs

  • When was Injeq founded?

    Injeq was founded in 2010.

  • Who is the founder of Injeq?

    Jari Hyttinen Ph.D, Riitta Seppänen-Kaijansinkko Ph.D, and Kai Kronström are the founders of Injeq.

  • Who is the CEO of Injeq?

    Timo Hänninen is the CEO of Injeq.

  • Where is Injeq headquartered?

    Injeq is headquartered in Tampere, Finland.

  • What is the size of Injeq?

    Injeq has 16 total employees.

  • What industry is Injeq in?

    Injeq’s primary industry is Medical Supplies.

  • Is Injeq a private or public company?

    Injeq is a Private company.

  • What is Injeq’s current revenue?

    The current revenue for Injeq is 00000.

  • How much funding has Injeq raised over time?

    Injeq has raised $7.25M.

  • Who are Injeq’s investors?

    Tesi, Ely Keskus, Finnish Business Angels Network, and Finnvera have invested in Injeq.

  • Who are Injeq’s competitors?

    Novosanis, NanoPass Technologies, and PharmaJet are competitors of Injeq.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »